Simplify Medical completes enrollment for Simplify Disc trial at 16 US sites — 5 insights

Written by Megan Wood | February 14, 2018 | Print  |

Simplify Medical concluded enrollment for its U.S. investigational device exemption trial testing the Simplify cervical artificial disc.

Here are five insights:


1. The company capped enrollment at 166 patients at 16 sites across the country.


2. The trial is assessing the Simplify Disc for one-level cervical implantation between C3-C7.


3. Domagoj Coric, MD, of Charlotte-based Carolina Neurosurgery and Spine Associates, and Richard Guyer, MD, of Plano-based Texas Back Institute Foundation, are serving as national co-primary investigators.


4. The Simplify Disc is made mostly of PEEK-on-ceramic, allowing its visibility on MRI.


5. The Simplify Disc already has the CE Mark.


More articles on devices:
Stryker achieves 95% ownership of Vexim: 5 takeaways
Zimmer Biomet, Stryker, Smith & Nephew & more: 16 device company notes
5 things to know about Stryker CEO Kevin Lobo


© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months